Cresco Labs (OTCMKTS:CRLBF – Get Free Report) and Akanda (NASDAQ:AKAN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.
Valuation & Earnings
This table compares Cresco Labs and Akanda’s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cresco Labs $770.89 million 0.99 -$179.85 million ($0.54) -4.07 Akanda $2.62 million 0.68 -$11.66 million N/A N/A
Akanda has lower revenue, but higher earnings than Cresco Labs.
Insider and Institutional Ownership 0.1% of Cresco Labs shares are owned by institutional investors. Comparatively, 0.8% of Akanda shares are owned by institutional investors. 20.4% of Akanda shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Analyst Recommendations
This is a breakdown of current recommendations for Cresco Labs and Akanda, as reported by MarketBeat.com.
Sell Ratings Hold
